Prognostic significance of CCT5 in breast cancer and its regulatory mechanisms in promoting tumorigenesis

This study explored the prognostic significance, biological functions, and molecular mechanisms of the chaperone CCT5 in breast cancer (BC), aiming to provide a theoretical basis for prognosis and targeted therapy. Key dependency genes in BC were screened via the DepMap database. Differential expression and prognostic analyses were performed using TCGA and GEO datasets, identifying CCT5 as the target gene. CCT5 expression in BC clinical tissues was validated by qRT-PCR, Western blot, and immunohistochemistry, followed by correlation analyses with clinical characteristics and prognosis. Stable CCT5 overexpression and knockdown cell models were established to assess effects on proliferation, migration, and invasion. WGCNA and enrichment analyses explored potential mechanisms, while Western blot and Nutlin-3 rescue assays verified regulation of the p53 pathway, with in vivo xenograft models used for final validation. CCT5 acted as a core dependency gene supporting BC cell survival. High CCT5 expression was significantly associated with poorer overall and disease-free survival, and correlated with larger tumor size, higher histological grade, positive lymph node metastasis, HER2-positive status, and elevated Ki-67 index. Functional assays showed that CCT5 overexpression enhanced proliferation, migration, and invasion, whereas knockdown suppressed these phenotypes. Mechanistically, CCT5 facilitated BC progression via negative regulation of the p53 pathway. Rescue experiments and in vivo xenograft models confirmed that the p53 activator Nutlin-3 reversed both p53 pathway inhibition and the oncogenic effects driven by CCT5 overexpression. High CCT5 expression is associated with poor prognosis. CCT5 functions as a key oncogene in BC and drives tumor progression through negative regulation of the p53 signaling pathway. This study provides comprehensive insights into the role and mechanisms of CCT5 in BC, thereby offering theoretical support for its potential as a therapeutic target.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-10-05
DOI
https://doi.org/10.1038/s41598-026-72762-x
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic significance of CCT5 in breast cancer and its regulatory mechanisms in promoting tumorigenesis

Jianwen Wang, Quan Liu, Yuming Chen, Tianlang Pei et al.
Scientific Reports
Breast Cancer Treatment Studies
article

Prognostic significance of CCT5 in breast cancer and its regulatory mechanisms in promoting tumorigenesis

Jianwen Wang, Quan Liu, Yuming Chen, Tianlang Pei, Min Cheng, Xintao Deng, Qiang Zhu, Wenjing Xu, Genbao Zhao, Xiang Li
article en

Abstract

This study explored the prognostic significance, biological functions, and molecular mechanisms of the chaperone CCT5 in breast cancer (BC), aiming to provide a theoretical basis for prognosis and targeted therapy. Key dependency genes in BC were screened via the DepMap database. Differential expression and prognostic analyses were performed using TCGA and GEO datasets, identifying CCT5 as the target gene. CCT5 expression in BC clinical tissues was validated by qRT-PCR, Western blot, and immunohistochemistry, followed by correlation analyses with clinical characteristics and prognosis. Stable CCT5 overexpression and knockdown cell models were established to assess effects on proliferation, migration, and invasion. WGCNA and enrichment analyses explored potential mechanisms, while Western blot and Nutlin-3 rescue assays verified regulation of the p53 pathway, with in vivo xenograft models used for final validation. CCT5 acted as a core dependency gene supporting BC cell survival. High CCT5 expression was significantly associated with poorer overall and disease-free survival, and correlated with larger tumor size, higher histological grade, positive lymph node metastasis, HER2-positive status, and elevated Ki-67 index. Functional assays showed that CCT5 overexpression enhanced proliferation, migration, and invasion, whereas knockdown suppressed these phenotypes. Mechanistically, CCT5 facilitated BC progression via negative regulation of the p53 pathway. Rescue experiments and in vivo xenograft models confirmed that the p53 activator Nutlin-3 reversed both p53 pathway inhibition and the oncogenic effects driven by CCT5 overexpression. High CCT5 expression is associated with poor prognosis. CCT5 functions as a key oncogene in BC and drives tumor progression through negative regulation of the p53 signaling pathway. This study provides comprehensive insights into the role and mechanisms of CCT5 in BC, thereby offering theoretical support for its potential as a therapeutic target.

Scientific Reports
Nantong University (CN), Xintai People's Hospital (CN), Xinghua People's Hospital Affiliated to Yangzhou University (CN)
Openalex Percentile: Top 17%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.